| | | | |
|
|
|  | Applying the New WHO in Your Diagnostic Practice |
| | FNA of Lymphoma, Essentials of: What the Oncologist Needs to Know From the Pathologist in Order to Treat the Patient |
| | Histiocytic Neoplasms, Dealing with the |
| | Medicolegal Situations in Hematopathology, Common |
| | Pulmonary Langerhans Cell Histiocytosis |
|
|
| Lymphoid |
| | Acute Leukemias, An Algorithmic Approach to the Classification of |
| | Anaplastic Large Cell Lymphoma (ALCL) Presenting in Bone Marrow |
| | Anaplastic Large Cell Lymphoma (ALCL) Presenting in Bone Marrow |
| | Anaplastic Large Cell Lymphoma (ALCL) Presenting in Bone Marrow |
| | Concurrent Massive Bone Marrow Effacement, Classic HCL Manifesting in Peripheral Lymph Node with |
| | Hematopoietic and Lymphoid Tissues, Classification of Tumors of |
| | Multiple Myeloma and Related Disorders in 2010, What's New for the Treatment of |
| | Plasma Cell Myeloma, Genetic Events in the Pathogenesis of |
| | Plasma Cell Myeloma, Molecular Classification of |
| | Role of Flow Cytometry in Myeloma, New Diagnosis and MRD |
| | T-Cell Large Granular Lymphocytic Leukemia |
|
Myelodysplasia |
| | Myelodysplastic Syndromes and Related Disorders, Diagnosis and Classification |
|
Myeloid |
| | Acute Leukemias |
|  | Acute Myeloid Leukemia with Inv(3)(q21q26.2) |
| | Acute Myeloid Leukemia, Methylomic Profiling |
| | An Algorithmic Approach to the Classification of Acute Leukemias |
| | Bone Marrow Biopsy, The Use of to Document the Proliferative Effects of Hematopoietic Growth Factors on Bone Marrow Cells |
| | Childhood Acute Lymphoblastic Leukemia, Minimal Residual Disease in |
| | Chronic Myelogenous Leukemia: Molecular Analysis for Diagnosis, Monitoring and Drug Resistance |
| | Chronic Myeloproliferative Disease, Bone Barrow Histopathology in the Diagnosis of the Early Stage of |
| | Classification of Tumors of Hematopoietic and Lymphoid Tissues |
| | FIP1L1-PDGFRA Positive Myeloproliferative Neoplasm |
| | JAK2V617F and Other Novel Mutations in Myeloproliferative Disorders |
| | Juvenile Myelomonocytic Leukemia: Bench to Bedside and Back Again |
| | Mast Cell Disease |
| | Minimal Residual Acute Leukemic Disease |
| | Mixed Phenotype Acute Leukemia, B/myeloid, NOS |
| | Molecular Monitoring Strategies to Track Response to BCR-ABL Kinase Inhibitors in CML |
| | Molecular Pathology of AML |
| | Myelodysplastic Syndromes and MicroRNAs |
| | Myelodysplastic Syndromes and Myeloproliferative Disorders |
| | Myelodysplastic/Myeloproliferative Diseases |
| | Myelofibrosis, Early Stage Primary |
| | Myeloid Sarcoma, NPM1c positive |
| | Myeloproliferative Disorders, The Diagnostic Interface Between Clinical Presentation, Pathology, and Molecular Tests in |
| | Myeloproliferative Neoplasms, Overview |
| | Myeloproliferative/Myelodysplastic Overlap Syndromes, Practical Issues in the Diagnosis of |
| | Parvovirus B19 Infection with Severe Anemia, Fetal Hydrops and Cardiomegaly Leading to Intrauterine Fetal Demise |
| | Pediatric Acute Leukemia: The Molecular Pathology of Pediatric Acute Leukemia |
| | Prefibrotic Stage, Chronic Idiopathic Myelofibrosis |
| | Refractory cytopenia with multilineage dysplasia (RCMD) |
| | Systemic Mast Cell Disease with an Associated Clonal Hematologic Non Mast Cell Lineage Disease (SM-AHNMD) |
| | Systemic Mastocytosis |
|
Other, including benign and reactive conditions |
| | Leukemias and Lymphomas, The Rational Use of Molecular Studies in (Short Course) |
|
|
| B cell lymphoma |
| | B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Burkitt Lymphoma |
| | Cutaneous B-cell Lymphoma |
| | Cutaneous B-cell Lymphomas, Low Grade : Similarities and Differences with Nodal Counterparts |
| | Cutaneous Large B-cell Lymphomas |
| | Cutaneous Lymphoid Hyperplasia |
| | Cutaneous Lymphomas Composed of Large B-cell Lymphocytes |
| | Cutaneous Lymphomas, Benign Mimics of |
| | Kaposi's Sarcoma Herpesvirus and Lymphoid Malignancies |
| | Secondary Lymphomas of the Skin |
| | Skin Biopsy, Scalp, Cutaneous Follicle Center Lymphoma, Grade 2 |
|
Other, including benign and reactive conditions |
| | Cutaneous Lymphoma, Inflammatory Lesions Simulating |
| | Cutaneous Lymphoma, WHO-EORTC Classification for |
| | Lymphomatoid Papulosis, What is: Lymphoid Hyperplasia or Lymphoma? |
|
T cell lymphomas |
| | CD30+ Lymphoproliferative Disorders of the Skin |
| | Cutaneous T, NK, and Precursor Lymphomas, Other |
| | Extranodal NK/T-cell Lymphoma, Nasal Type Primarily Involving the Skin and Lymph Nodes |
| | Mycosis Fungoides and Precursor Lesions |
| | Mycosis Fungoides and Variants |
| | Mycosis Fungoides, Diagnosis of the Early Lesions of |
| | Primary Cutaneous Anaplastic Large Cell Lymphoma |
| | Primary Cutaneous T-cell & NK-Cell Lymphomas |
| | Spectrum of Cutaneous CD30-Positive Lymphoproliferative Disorders |
| | Subcutaneous Panniculitis-Like T Cell Lymphoma |
|
|
| | Anti-immunoglobin Heavy Chain (IgG, IgA, IgM) |
| | Anti-lambda and Anti-kappa Light Chain |
| | Apoptosis by In-situ End Labeling |
| | BCL-2 |
| | CD117 (c-KIT) |
| | CD138 (Syndecan-1) |
| | CD15 |
| | CD1a and S-100 |
| | CD2, CD7, TIA-1 - Other T-cell Markers |
| | CD20 (L-26) |
| | CD3 |
| | CD30 (BerH2) |
| | CD34 |
| | CD43 |
| | CD45RB (Leucocyte Common Antigen) |
| | CD5, CD23, CD10 - Other Markers Used to Study B-cell Proliferations |
| | CD56 (N-CAM) |
| | CD68 |
| | CD79a (HM57) |
| | CD99 |
| | Cyclin D1 |
| | DBA.44 |
| | Hematolymphoid Proliferations, Panel Approach to |
| | Hemoglobin |
| | Lymphoma Diagnosis, New Techniques of Immunohistochemistry (IHC) and in situ Hybridization (ISH) for |
| | Lysozyme |
| | Myeloperoxidase |
| | Proliferation-associated Markers: PC10 And MIB-1 |
| | Tartrate Resistant Acid Phosphatase |
| | TdT |
| | von Willebrand Factor (Factor VIII-Related Antigen) |
|
|
| General |
| | Early Lymphoid Lesions (To include discussion of In-Situ Mantle Cell Lymphoma, In-Situ Follicular Lymphoma, Monoclonal Light Chain Lesions in pediatric patients, Monoclonal B-cell lymphocytosis) |
| | Immunodeficiency-Associated Lymphoid Proliferations (To include discussion of ALPS, HIV, and HHV8) |
| | Lymphoid Proliferations of Unknown Etiology (To include discussion of IgG4 Associated Sclerosing Lesions, Kikuchi, Kimura, and Coexistent Sinus Histiocytosis with Massive Lymphadenopathy and Langerhans Histiocytosis) |
| | Lymphoma and the One Health Paradigm |
| | Therapy-Associated Lymphoid Proliferations (To include discussion of Methotrexate, Immunomodulator-Associated, Secondary ALL, Anti-Convulsant Hyperplasias) |
| | Viral-Associated Lymphoid Proliferations (To include discussion of EBV, CMV, HSV, and HHV6) |
| B cell lymphoma |
| | Age-related Epstein-Barr Virus-Associated B-cell Lymphoproliferative Disorders |
| | Aggressive B-cell Lymphomas Associated with Immunosuppression |
| | Angiotropic Large Cell Lymphoma |
| | B Cell Lymphoma, Unclassifiable, with Features Intermediate Between DLBCL and Burkitt Lymphoma |
| | B-Cell Lymphoma |
| | B-cell Lymphomas, Morphologic and Molecular Characteristics, Transformation of Low Grade to Aggressive |
| | B-cell Neoplasms |
| | B-Cell Neoplasms, What to Know About the |
| | CD20(+), Cyclin D1(+)Plasma Cell Myeloma |
| | Classic HCL Manifesting in Peripheral Lymph Node with Concurrent Massive Bone Marrow Effacement |
| | Classical Burkitt Lymphoma and Variants: Strategies for Accurate Diagnosis |
| | Concurrent Massive Bone Marrow Effacement, Classic HCL Manifesting in Peripheral Lymph Node with |
| | Diffuse Large B Cell Lymphoma: Morphological and Immunohistochemical Correlations |
| | Diffuse Large B-Cell Lymphoma, consistent with Mediastin |
| | Diffuse Large Cell Lymphoma, Molecular Pathogenesis of |
| | DLBCL From Biomarkers to Novel Mechanisms and New Therapies |
| | Epstein-Barr Virus and Lymphoproliferative Disorders in Iatrogenic Immunodeficiency |
| | Expression Arrays and Genomic Profiling of Aggressive B-cell Lymphoma, Insights from |
| | Extranodal Marginal Zone B-cell Lymphoma of MALT Type, with Focal Transformation to Large Cell Lymphoma, of the Parotid Gland |
| | Extranodal Marginal Zone B-cell Lymphoma of Mucosa Associated Lymphoid Tissue (MALT)-type with Light Chain Deposition. Non-necrotizing Granulomatous Inflammation Suggestive of Sarcoid. |
| | FNA Biopsy of a Right Axillary Lymph Node. |
| | Follicular Lymphoma Transformation: Novel Insights from Proteomic Studies |
| | Follicular Lymphoma, Grade 1 (Of 3) |
| | Follicular Lymphoma, Grade 1 of 3, with Numerous Signet Ring Cells (Short Course) |
| | Gene Expression Profiling in Diffuse Large B-Cell Lymphoma: New Insights into Molecular Heterogeneity and Rational Treatment Targets |
| | Histogenetic Phenotypes of B Cells in Posttransplant Lymphoproliferative Disorders by Immunohistochemical Analysis Correlate with Transplant Type: Solid Organ vs. Hematopoietic Stem Cell Transplantation |
| | Immunosecretory Disorders |
| | Infective Etiologies of MALT Lymphomas: Biological and Clinical Correlations |
| | Intravascular Large B-cell Lymphoma |
| | Lymphoid Follicles and Lymphoid Hyperplasia vs. Lymphoma |
| | Lymphomatoid Granulomatosis |
| | Malignancies of the Genitourinary Organs, Hematologic |
| | MALT Lymphoma, Infectious Etiologies of |
| | MALT Lymphomas: Genetic Changes, Their Detection and Significance |
| | Mantle Cell Lymphoma |
| | Mantle Cell Lymphoma (MCL), with Peripheral Blood Involvement (Short Course) |
| | Mantle Cell Lymphoma, Small Cell Variant, with a Very Indolent Clinical Behavior |
| | Mediastinal Lymphomas: Practical and Theoretical Issues |
| | Nodular Mantle Cell Lymphoma, Cyclin D1-, Cyclin D3+ |
| | Plasmablastic Lymphoma (or diffuse large B-cell lymphoma, plasmablastic subtype) |
| | Primary Effusion Lymphoma |
| | Search for Novel Immunophenotypic Markers in Aggressive B-cell Lymphoma: The Growing List of Immunohistological Markers |
| | Transformation of CLL into a Diffuse Large B Cell Lymphoma with Anaplastic Morphology and a HL Component |
| | Tumor and Host Genetics in Risk Stratification in Aggressive B-cell Lymphomas |
|
Hodgkin lymphoma |
| | Bone, Ilium, Right, Biopsy: Malignant Lymphoma, Hodgkin Lymphoma, Nodular Sclerosis |
| | Hodgkin Lymphoma (HL), Extracellular Mediators in the Biology of |
| | Hodgkin Lymphoma: Diagnostic and Biological Insights |
| | Hodgkin's Disease |
| | Hodgkin's Lymphoma, History of the Modern Classifications of |
| | Hodgkin-like B-cell Lymphoproliferative Disorder |
| | Mixed Cellularity and Lymphocyte Depleted Hodgkin Lymphoma: Athology, Epidemiology, Clinical Features, and the Role of Epstein-Barr Virus |
| | Nodular Lymphocyte Predominant Hodgkin Lymphoma with Progression to T Cell-rich Diffuse Large B-cell Lymphoma |
| | Nodular Lymphocyte Predominant Hodgkin's Lymphoma (NLPHL) (Short Course) |
| | Nodular Lymphocyte Predominant Hodgkin's Lymphoma and T-cell rich/ Histiocyte-rich Large B-cell Lymphoma |
| | Nodular Sclerosis Hodgkin's Lymphoma and Mediastinal Large B-cell Lymphoma: Two Related Diseases? |
|
Other, including benign and reactive conditions |
| | Atypical Marginal Zone Hyperplasia Of Mucosa Associated Lymphoid Tissue: A Reactive Condition Of Childhood Showing Immunoglobulin Lambda Light Chain Restriction |
| | Autoimmune Lymphoproliferative Syndrome |
| | Castleman's Disease, Hyaline-Vascular Type (HVCD) (Short Course) |
| | Castleman's Disease, Multicentric, Plasma Cell Variant |
| | CD4-negative Blastic Plasmacytoid Dendritic Cell Neoplasm, Involving Bone Marrow, Skin, and Lymph Node, with Immunophenotypic Variability/Differentiation at Different Sites |
| | Chronic Granulomatous Disease (CGD) |
| | Common Hematopoietic and Solid Tumors of Childhood, A Practical Approach to the Diagnosis of (Short Course) |
| | Dendritic Histiocytoses: An Update |
| | Dr. Stout as I Knew Him AND Understanding Lymphomas |
| | FISH, CGH, and Array-CGH - New Advances in Cytogenetics |
| | Gastrointestinal Lymphomas, An Update on |
| | Hematolymphoid Neoplasms |
| | Hepatitis C Virus and Lymphoproliferative Disorders: The role of lymphoma microenvironment in Splenic Marginal Zone Lymphoma |
| | Histiocytic/dendritic-cell Neoplasms and Related Disorders |
| | Hyaline-Vascular Castleman Disease |
| | Interdigitating Dendritic Cell Sarcoma/Tumor (Short Course) |
| | Kaposi's Sarcoma Herpesvirus and Lymphoid Malignancies |
| | Langerhans' Cell Sarcoma (LCS) |
| | Lymphoma Diagnosis, New Techniques of Immunohistochemistry (IHC) and in situ Hybridization (ISH) for |
| | Lymphoma, Molecular Profiling Studies of |
| | Malignant Lymphomas |
| | Micronodular Thymoma with Lymphoid B-cell Hyperplasia |
| | PCR Techniques for Assessing Lymphoid Clonality, Standardization of - the Biomed-2 Experience |
| | Pediatric Non-Hodgkin Lymphomas |
| | Polymorphous Low-grade Adenocarcinoma with Papillary Growth and Metastases to Two Cervical Lymph Nodes |
|
T cell lymphomas |
| | AILT Classic Type (Short Course) |
| | Anaplastic Large Cell Lymphoma, Common Type, ALK1+ with Variant Translocation (Short Course) |
| | Anaplastic Large Cell Lymphoma, Molecular Aspects of |
| | Anaplastic Large Cell Lymphoma, Proteomic Studies of |
| | Anaplastic Large Cell Lymphoma: After Twenty Years the Controversy Continues |
| | CD15+/CD30+ Peripheral T Cell Transformation of Mycosis Fungoides |
| | CD4+/ CD56+ Tumors and the TCL-1 Oncogene |
| | HTLV1 and Cancer |
| | Peripheral T-cell Lymphoma, Not Otherwise Ppecified, Follicular Variant (WHO 2008) |
| | Peripheral T-cell Lymphoma, Simulating Hodgkin Lymphoma, |
| | Peripheral T-cell Lymphoma, Unspecified (PTCL-U) |
| | Peripheral T-cell Lymphomas and Angioimmunoblastic T-cell Lymphoma, Introduction to |
| | Peripheral T-NHL, Unspecified with B-cell Proliferation and RS-like Cells of B-cell Phenotype Associated with EBV (Short Course) |
| | Precursor T-cell Lymphoblastic Lymphoma with Eosinophils and Foci of Myeloid Differentiation |
| | Primary Gastric T-cell Lymphoma associated with Human T-cell Leukemia Virus Type I |
| | T and NK Cell Lymphomas |
| | T-cell Neoplasms |
|
T-Cell/NK Cell Neoplasms |
| | T and NK Cell Neoplasms, An Update |
|
|
| | Anaplastic Large Cell Lymphoma (Short Course) |
| | Colonic mantle cell lymphoma (multiple lymphomatous polyposis) (Short Course) |
| | Common Hematopoietic and Solid Tumors of Childhood, A Practical Approach to the Diagnosis of (Short Course) |
| | Follicular Lymphoma (Short Course) |
| | Gastric extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) type (Short Course) |
| | Hepatosplenic T-cell lymphoma (Short Course) |
| | Hodgkin's Lymphoma (Short Course) |
| | Infectious Mononucleosis (Short Course) |
| | Leukemias and Lymphomas, The Rational Use of Molecular Studies in (Short Course) |
| | Leukemias and Lymphomas, The Rational Use of Molecular Studies in (Short Course) |
| | Lymphoblastic Lymphoma (Short Course) |
| | Mantle Cell Lymphoma (Short Course) |
| | Nasal/Nasal type NK/T-cell lymphoma (Short Course) |
| | Primary cutaneous anaplastic large cell lymphoma (ALCL) (Short Course) |
| | Reactive Lymphoid Hyperplasia (Short Course) |
| | Salivary gland extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) type (Short Course) |
| | Splenic marginal zone lymphoma (Short Course) |
| | Subcutaneous panniculitis-like T-cell lymphoma (Short Course) |
| | Suppurative Granulomatous Lymphadenitis (Short Course) |
|
|
| | Inflammatory Pseudotumor of Spleen |
| | Inflammatory Pseudotumor of Spleen |
| | Sickle Cell Anemia |
| | Splenic Angiomatoid Nodular Transformation (SANT) and Lymphangioma (Short Course) |
|
|
| | Anaplastic Large Cell Lymphoma, ALK-1 Positive, Presenting with Retroperitoneal Fibrosis |
| | Anaplastic Large Cell Lymphoma, Molecular Aspects of |
| | Anaplastic Large Cell Lymphoma, Proteomic Studies of |
| | Diffuse Large Cell Lymphoma, Molecular Pathogenesis of |
| | FISH, CGH, and Array-CGH - New Advances in Cytogenetics |
| | Follicular Lymphoma Transformation: Novel Insights from Proteomic Studies |
| | Hematopathology, Practical Use of New Technologies in |
| | Hepatitis C Virus and Lymphoproliferative Disorders: The role of lymphoma microenvironment in Splenic Marginal Zone Lymphoma |
| | In Situ Hybridization in Hematopathology |
| | Leukemias and Lymphomas, The Rational Use of Molecular Studies in (Short Course) |
| | Lymphoma, Molecular Profiling Studies of |
| | Lymphoma: Introduction and Overview of Proteomics |
| | Malignant Lymphoma into Clinical Application, Translating Mass Spectrometry-Based Proteomics of |
| | Malignant Lymphoma, High Throughput Sequencing |
| | Mass Spectrometry-Based Proteomics, Introduction to |
| | Molecular Monitoring Strategies to Track Response to BCR-ABL Kinase Inhibitors in CML |
| | Myeloproliferative Disorders, The Diagnostic Interface Between Clinical Presentation, Pathology, and Molecular Tests in |
| | PCR Techniques for Assessing Lymphoid Clonality, Standardization of - the Biomed-2 Experience |
| | Proteomics and Lymphoid Malignancies |
